Clear cell variant of squamous cell carcinoma originating in the esophagus: Report of a case with immunohistochemical and oncogenetic analyses

Pathology International

Volumn 62, Issue 2, 2012, Pages 137-143

  Imamhasan, Abdukadir ^a,b   Mitomi, Hiroyuki ^a   Saito, Tsuyoshi ^a   Arakawa, Atsushi ^a   Yao, Takashi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b First Hospital of Xin Jiang Medical University   (China)

Author keywords

Clear cell; Cytokeratin; Esophagus; Immunohistochemistry; Squamous cell carcinoma

Indexed keywords

B RAF KINASE; BETA CATENIN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 7; CYTOKERATIN 8; GLYCOGEN; K RAS PROTEIN; PROTEIN P16; PROTEIN P53;

AGED; ARTICLE; CANCER CELL; CANCER SURGERY; CASE REPORT; CLEAR CELL CARCINOMA; ELECTRON MICROSCOPE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRASTRUCTURE;

AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HUMANS; MALE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84855944281     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02758.x     Document Type: Article

References (27)

1. Kuo T. Clear cell carcinoma of the skin: A variant of the squamous cell carcinoma that simulates sebaceous carcinoma. Am J Surg Pathol 1980; 4: 573-83.
2. Requena L, Sánchez M, Requena I, Alegre V, Sánchez Yus E. Clear cell squamous cell carcinoma. A histologic, immunohistologic, and ultrastructural study. J Dermatol Surg Oncol 1991; 17: 656-60.
3. Al-Arashi MY, Byers HR. Cutaneous clear cell squamous cell carcinoma in situ: Clinical, histological and immunohistochemical characterization. J Cutan Pathol 2007; 34: 226-33.
4. Dalton SR, LeBoit PE. Squamous cell carcinoma with clear cells: How often is there evidence of tricholemmal differentiation? Am J Dermatopathol 2008; 30: 333-9.
5. Ostler DA, Prieto VG, Reed JA, Deavers MT, Lazar AJ, Ivan D. Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: An immunohistochemical study of 117 cases. Mod Pathol 2010; 23: 567-73.
6. Wong T-Y, Suster S, Nogita T, Duncan LM, Dickersin RG, Mihm MC Jr. Clear cell eccrine carcinomas of the skin. A clinicopathologic study of nine patients. Cancer 1994; 73: 1631-43.
7. Kawaguchi K, Oda Y, Nakanishi K etal. Malignant transformation of renal angiomyolipoma: A case report. Am J Surg Pathol 2002; 26: 523-9.
8. Iwao K, Nakamori S, Kameyama M etal. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 1998; 58: 1021-6.
9. Takubo K, Esaki Y, Watanabe A, Umehara M, Sasajima K. Adenoma accompanied by superficial squamous cell carcinoma of the esophagus. Cancer 1993; 71: 2435-8.
10. Endoh Y, Miyawaki M, Tamura G, Watanabe H, Motoyama T. Esophageal adenocarcinoma that probably originated in the esophageal gland duct: A case report. Pathol Int 1999; 49: 156-9.
11. Harada O, Ota H, Katsuyama T, Hidaka E, Ishizaka K, Nakayama J. Esophageal gland duct adenoma: Immunohistochemical comparison with the normal esophageal gland and ultrastructural analysis. Am J Surg Pathol 2007; 31: 469-75.
12. Yada K, Kashima K, Daa T, Kitano S, Fujiwara S, Yokoyama S. Expression of CD10 in basal cell carcinoma. Am J Dermatopathol 2004; 26: 463-71.
13. Guillem P, Billeret V, Buisine MP etal. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus. Int J Cancer 2000; 88: 856-61.
14. Sagara M, Yonezawa S, Nagata K etal. Expression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma: Its relationship with prognosis. Int J Cancer 1999; 84: 251-7.
15. Takubo K, Takai A, Yamashita K, Onda M. Carcinoma with signet ring cells of the esophagus. Acta Pathol Jpn 1987; 37: 989-95.
16. Levina E, Oren M, Ben-Ze'ev A. Downregulation of beta-catenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamics. Oncogene 2004; 23: 4444-53.
17. Sandig V, Brand K, Herwig S, Lukas J, Bartek J, Strauss M. Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat Med 1997; 3: 313-9.
18. ink4a/CDKN2 identifies patients with good prognosis. J Clin Oncol 2001; 19: 2272-81.
19. Coggi G, Bosari S, Roncalli M etal. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. Cancer 1997; 79: 425-32.
20. Hsu PK, Li AF, Wang YC etal. Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus. J Thorac Cardiovasc Surg 2008; 135: 1029-35.
21. Kudo J, Nishiwaki T, Haruki N etal. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer. World J Surg Oncol 2007; 5: 21.
22. Mir MM, Dar JA, Dar NA, Syed AT, Salam I, Lone GN. The association of beta-catenin gene mutations and human papillomavirus in carcinoma of esophagus in a high-risk population of India. Int J Health Sci (Qassim) 2007; 1: 177-83.
23. Takeuchi H, Ozawa S, Ando N etal. Further evidence that altered p16/CDKN2 gene expression is associated with lymph node metastasis in squamous cell carcinoma of the esophagus. Oncol Rep 2001; 8: 627-32.
24. Mercer KE, Pritchard CA. Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim Biophys Acta 2003; 1653: 25-40.
25. Sommerer F, Vieth M, Markwarth A etal. Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma. Oncogene 2004; 23: 554-8.
26. Lorenzen S, Schuster T, Porschen R etal. Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: A randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol 2009; 20: 1667-73.
27. Liu QW, Fu JH, Luo KJ etal. Identification of EGFR and KRAS mutations in Chinese patients with esophageal squamous cell carcinoma. Dis Esophagus. doi: 10.1111/j.1442-2050.2010.01155.x.